Novavax (NVAX) Earnings Date, Estimates & Call Transcripts $8.09 +0.03 (+0.37%) (As of 11/21/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Novavax Latest Earnings SummaryUpcoming Q4 Earnings DateFeb. 26EstimatedActual EPS (Nov. 12) -$0.76 Beat By $0.07 Consensus EPS (Nov. 12) -$0.83 Novavax posted Q3 2024 earnings on November 12, 2024, reporting an EPS of -$0.76, which beat analysts' consensus estimates of -$0.83 by $0.07. Quarterly revenue fell 54.8% year-over-year to $84.51 million, above analyst estimates of $65.80 million. With a trailing EPS of -$2.26, Novavax's earnings are expected to grow next year, from ($1.40) to ($0.13) per share. Conference Call TranscriptConference Call AudioEarnings Press ReleaseEarnings Slide DeckNVAX Upcoming EarningsNovavax's next earnings date is estimated for Wednesday, February 26, 2025, based off prior year's reporting schedules. Get Novavax Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Novavax and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataNVAX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.NVAX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Colonial MetalsA “Thank You Gift” From Pres. Trump - GeniusThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Novavax Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20243-$1.48-$0.85-$1.09Q2 20242-$1.23-$0.92-$1.08Q3 20243-$1.06-$0.64-$0.86Q4 20243-$0.71$1.50$0.07FY 202411-$4.48-$0.91-$2.95Q1 20252-$0.69-$0.49-$0.59Q2 20252-$0.66$0.65-$0.01Q3 20252-$0.40-$0.30-$0.35Q4 20252-$0.57$1.49$0.46FY 20258-$2.32$1.35-$0.49Q1 20261-$0.45-$0.45-$0.45 Novavax Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 2/26/2025(Estimated)------- 11/12/2024Q3 2024-$0.83-$0.76+$0.07-$0.76$65.80M$84.51M 8/8/2024Q2 2024$1.82$0.99 -$0.83$0.99$458.57M$415.50M 5/10/2024Q1 2024-$1.04-$1.05 -$0.01-$1.05$71.32M$93.90M 2/28/2024Q4 2023-$0.49-$1.44 -$0.95-$1.44$310.96M$291.34M 11/9/2023Q3 2023-$1.82-$1.26+$0.56-$1.26$171.04M$187.00M 8/8/2023Q2 2023-$1.24$0.58+$1.82$0.58$264.16M$424.40M Get the Latest News and Ratings for NVAX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Novavax and its competitors with MarketBeat's FREE daily newsletter. 5/9/2023Q1 2023-$3.38-$3.41 -$0.03-$3.41$94.52M$81.00M 2/28/2023Q4 2022-$0.92-$2.28 -$1.36-$2.28$383.14M$357.40M Novavax Earnings - Frequently Asked Questions When is Novavax's earnings date? Novavax has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates. Learn more on NVAX's earnings history. What guidance has Novavax issued on next quarter's earnings? Novavax updated its FY 2024 earnings guidance on Tuesday, November, 12th. The company issued revenue guidance of $650.0 million-$700.0 million, compared to the consensus revenue estimate of $761.5 million. Did Novavax beat their earnings estimates last quarter? In the previous quarter, Novavax (NASDAQ:NVAX) reported ($0.76) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.83) by $0.07. Learn more on analysts' earnings estimate vs. NVAX's actual earnings. How can I listen to Novavax's earnings conference call? The conference call for Novavax's latest earnings report can be listened to online. Listen to Conference Call How can I read Novavax's conference call transcript? The conference call transcript for Novavax's latest earnings report can be read online. Read Transcript How much revenue does Novavax generate each year? Novavax (NASDAQ:NVAX) has a recorded annual revenue of $983.71 million. How much profit does Novavax generate each year? Novavax (NASDAQ:NVAX) has a recorded net income of -$545.06 million. NVAX has generated -$2.26 earnings per share over the last four quarters. What is Novavax's EPS forecast for next year? Novavax's earnings are expected to grow from ($1.40) per share to ($0.13) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies RLAY Earnings ADPT Earnings KOD Earnings TWST Earnings IOVA Earnings DNLI Earnings CRSP Earnings ALKS Earnings FOLD Earnings GERN Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report A “Thank You Gift” From Pres. Trump - Genius (Ad)The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide This page (NASDAQ:NVAX) was last updated on 11/22/2024 by MarketBeat.com Staff From Our Partners[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredMy favorite credit card just increased its sign-up bonusTired of getting average credit card rewards? This credit card just increased its sign-up bonus to 75,000 bonu...Card Ratings | SponsoredNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredWhy Buffett, Bezos & Congress Are Rushing Into This SectorWhy are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novavax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Novavax With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
